- Therapeutic Focus: Rare Diseases
- Therapeutic Focus: Cardiovascular
- Therapeutic Focus 2014: Metabolic
- Therapeutic Focus 2014: Respiratory
- Therapeutic Focus 2014: Rheumatology
- Therapeutic Focus 2014: Infectious Diseases
- Therapeutic Focus 2014: Oncology
- Therapeutic Focus 2014: Women's Health
- Therapeutic Focus 2014: Vaccines
- Therapeutic Focus 2014: Neurology
MM&M senior editor, Larry Dobrow, discusses sales force enablement with Rich Daly, managing partner at RavineRock Partners and former president of US diabetes for AstraZeneca.
MM&M senior editor Larry Dobrow discusses how to optimize the user experience on digital sales tools with Jose Andrade, VP, director of interactive technology and Emily Tower, VP of digital strategy and analytics for AbelsonTaylor.
MM&M senior editor, Larry Dobrow, discusses innovation in diabetes with Guy Platt, business development executive of Boston Therapeutics.
MM&M senior editor, Larry Dobrow, discusses reaching no-see physicians with Kevin Dunn, SVP of strategy and Lauren Hartkorn, account director of True Health + Wellness.
MM&M Executive Editor, Marc Iskowitz, discusses pharma's digital maturation process with Peter Korian, President and Founder of IOMEDIA. [SPONSORED CONTENT]
R.J. Lewis, President and CEO of e-Healthcare Solutions, shares his unique views on informed targeting with Marc Iskowitz, MM&M Executive Editor. [SPONSORED CONTENT]
Jayson Mercado, head of digital events at ExL Pharma, chats to MM&M Executive Editor, Marc Iskowitz, about the changing industry landscape and the evolution of digital. [SPONSORED CONTENT]
PSKW leadership duo, Robert Previdi, Founder and CEO, and Chris Dowd, SVP, Market Product Development, share their perspectives on pharma loyalty-marketing programs with MM&M Executive Editor, Marc Iskowitz. [SPONSORED CONTENT]
MM&M Executive Editor, Marc Iskowitz, catches up with Bryon Main, Principal and Founder of ExL Pharma, to discuss the changing industry landscape and the evolution of digital. [SPONSORED CONTENT]
R.J. Lewis, President and CEO of e-Healthcare Solutions, offers his unique take on digital pharma trends in a conversation with MM&M Editor in Chief, James Chase. [SPONSORED CONTENT]
Scott Weintraub, CMO and Principal at Healthcare Regional Marketing, chats to MM&M Editor in Chief, James Chase, about the transformation of the healthcare marketing model. [SPONSORED CONTENT]
Professional Ad Reports
No one expected the numbers to be pretty. And medical/surgical journals' latest losses weren't. Larry Dobrow analyzes the numbers for the first half of 2013 by advertisers and brands
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.